← brief for 2026-10-09 · Slowing decline

EFFECT OF SGLT2 INHIBITORS ON MARKERS OF PYROPTOSIS AND RENAL INFLAMMATION IN DIABETIC NEPHROPATHY: A SYSTEMATIC REVIEW

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

This review looked at how a common diabetes drug affects kidney inflammation. It found the drug may lower markers of a specific type of cell death. This process can speed up kidney scarring. The review suggests this drug helps protect the kidney by calming this inflammation.

Who did this work

Estrella-Rubí-Frausto-De la Cruz · Marco-Antonio-Jiménez-López · Zaid-Emiliano-Badillo-Mireles · Yaxel-Herrada-Ávila · Leonardo-Gabriel-Guzmán-Arteaga · Ángel-Daniel-Frayre-Chairez · Alexa-Lizeth-Esquivel-Torres

Source

Article · OpenAlex, CKD works · 2026-10-08
https://doi.org/10.30574/gscarr.2026.29.1.0253